Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 112   

Articles published

SHP 3,901.00 +53.00 (1.38%)
price chart
AbbVie says $55 billion acquisition of Shire officially dead
(Reuters) - U.S. drugmaker AbbVie Inc (ABBV.N) said on Monday it has reached agreement with Shire Plc (SHP.L) to officially call off its proposed $55 billion purchase of the Irish company, and will pay Shire a $1.64 billion breakup fee for walking away ...
Is Shire PLC A Buy After AbbVie Inc Withdraws Takeover Offer?  The Motley Fool UK
Turning Away From Shire May Cost AbbVie More Than Lost Tax Savings  Bidness ETC
Related articles »  
How Much Lower Can Shire PLC Go?
This news comes after AbbVie's announcement yesterday that the company was reconsidering its offer to acquire Shire, after taking into account the US Treasury's new rules on tax inversion deals.
Why Shire plc (ADR) Is Today's Worst Biotech Stock  Motley Fool
Shire: AbbVie should proceed with $55B acquisition  Bloomington Pantagraph
Related articles »  
Top Allergan holder Paulson urges deal with Shire: sources
(Reuters) - Allergan Inc (AGN.N) shareholder Paulson & Co is urging the Botox maker to merge with specialty pharmaceutical company Shire Plc (SHP.L) as an alternative to a deal with hostile bidder Valeant Pharmaceuticals International Inc (VRX.TO) ...
Allergan Might Approach Shire For Acquisition  Bidness ETC
Related articles »  
Shire PLC Takes a Dive as AbbVie Reconsiders Offer
Billionaire stock picks Paramount Gold and Silver Corp. (NYSEMKT:PZG), Nanosphere, Inc. (NASDAQ:NSPH) and Orexigen Therapeutics, Inc. (NASDAQ:OREX) have made noteworthy climbs on the market this Wednesday.
Shire PLC Upgraded to Buy by CRT Capital (SHPGY)  WKRB News
Buy Shire PLC (ADR)(NASDAQ:SHPG) on Weakness: CRT Capital  Street Newswire (registration)
Related articles »  
Why Shire PLC, Hikma Pharmaceuticals Plc And BTG plc Could Complement ...
Investor sentiment in the pharmaceutical sector has weakened considerably in recent days after AbbVie decided to ditch its bid for Shire (LSE: SHP) (NASDAQ: SHPG.US). The reason for it is a closing of a loophole that allowed US companies to relocate ...
Related articles »  
Shire PLC's Shares Collapse As AbbVie Inc Reconsiders
The deal between Shire and AbbVie is not over just yet. AbbVie has only stated that it is reconsidering the deal, although the market seems to believe that the company will walk away altogether.
UPDATE: Deutsche Bank Resumes Coverage On Shire
Deutsche Bank resumed coverage of Shire PLC (NASDAQ: SHPG) Tuesday with a Buy rating and $220 price target. "Despite the distractions of the merger process with AbbVie, the company continues to perform well: better-than-expected 2Q results led to a ...
Shire PLC Price Target Raised to GBX 4550 at Deutsche Bank (SHP)
Shire PLC logo Equities research analysts at Deutsche Bank hoisted their price target on shares of Shire PLC (LON:SHP) from GBX 4,350 ($70.00) to GBX 4,550 ($73.22) in a research note issued to investors on Wednesday.
Deutsche Bank Increases Shire PLC Price Target to GBX 4550 (SHP)  Intercooler
Shire PLC's Market Perform Rating Reiterated at Sanford C. Bernstein (SHP)  Watch List News (press release)
Related articles »  
Latest Updates on Shire PLC (ADR) (NASDAQ:SHPG)
Shire PLC (ADR) (NASDAQ:SHPG) announces that James Bowling, Interim Chief Financial Officer (CFO), has notified the Board of Directors of his decision to step down from his current role to pursue a new career opportunity as CFO of Severn Trent plc.
AbbVie, Shire Terminate Year's Biggest Deal
AbbVie Inc. and Shire PLC officially agreed to terminate their $54 billion deal, killing the year's biggest agreed-upon merger and giving a win to the Obama administration, which has fought overseas merger deals prompted by tax advantages.